𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CD95 and CD95-ligand expression in endocrine pancreas of NOD, NOR and BALB/c mice

✍ Scribed by A. Signore; A. Annovazzi; E. Procaccini; P. E. Beales; J. Spencer; R. Testi; G. Ruberti


Publisher
Springer
Year
1997
Tongue
English
Weight
577 KB
Volume
40
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Regulation of CD95 (APO-1/ FAS) ligand a
✍ Cordula Moers; Ulrich Warskulat; Markus MΓΌschen; Jos Even; Dieter Niederacher; R πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 337 KB πŸ‘ 2 views

CD95 (Apo-1/Fas) ligand (CD95L) expression has been observed in various malignancies. In human primary cell lines from a squamous cell carcinoma (SCC) of the vulva, the effect of cisplatin (CDDP) and IFNβ₯ on the expression of CD95L and its 2 receptor isoforms, CD95 transmembrane (CD95tm) and CD95 so

Regulation of CD95 (APO-1/Fas) receptor
✍ Markus MΓΌschen; Ulrich Warskulat; Patrice Douillard; Emmanuelle Gilbert; Dieter πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 179 KB

The effect of lipopolysaccharide (LPS) on the expression of CD95 (APO-1/Fas) receptor and ligand (CD95L) was studied in primary cultures of rat liver Kupffer cells (KCs), sinusoidal endothelial cells (SECs), and parenchymal cells (PCs) at the messenger RNA (mRNA) level and by means of immunocytochem